| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-02-15 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | -0.130 | -0.0500 | ||||
| REV | 4.977K |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of PetVivo Holdings (NASDAQ: PETV) through any online brokerage.
Other companies in PetVivo Holdings’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Tivic Health Systems (NASDAQ:TIVC), Motus GI Hldgs (NASDAQ:MOTS) and NeuroOne Medical Tech (NASDAQ:NMTC).
The latest price target for PetVivo Holdings (NASDAQ: PETV) was reported by ThinkEquity on October 12, 2021. The analyst firm set a price target for 7.00 expecting PETV to rise to within 12 months (a possible 170.27% upside). 1 analyst firms have reported ratings in the last year.
The stock price for PetVivo Holdings (NASDAQ: PETV) is $2.59 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for PetVivo Holdings.
PetVivo Holdings’s $Q3 earnings are confirmed for after-market on February 15, 2022.
There is no upcoming split for PetVivo Holdings.
PetVivo Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.